Dr. David Molthrop, M.D.
What this data tells you about Dr. Molthrop
Dr. David Molthrop is a medical oncology in Winter Park, FL, with 19 years in practice. Based on federal Medicare data, Dr. Molthrop performed 88,412 Medicare services across 3,702 unique beneficiaries.
Between the years covered by Open Payments, Dr. Molthrop received a total of $44,120 from 33 pharmaceutical and/or device companies across 151 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Molthrop is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Anti-nausea injection (aprepitant) | 16,770 | $1 | $5 |
| Pembrolizumab injection (Keytruda) | 14,200 | $43 | $137 |
| Iron sucrose injection (Venofer) | 14,100 | $0 | $5 |
| Daratumumab injection (Darzalex) | 11,160 | $38 | $110 |
| Iron infusion (Feraheme) | 8,670 | $0 | $4 |
| Dexamethasone injection (steroid) | 3,613 | $0 | $3 |
| Complete blood count (CBC) with differential | 2,769 | $8 | $29 |
| Blood draw (venipuncture) | 2,705 | $8 | $9 |
| Epoetin alfa injection (Procrit) for anemia | 2,580 | $6 | $23 |
| Injection, fulvestrant, 25 mg | 2,220 | $8 | $132 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,890 | $1 | $28 |
| Denosumab injection (Prolia/Xgeva) | 1,440 | $18 | $51 |
| Injection of additional new drug or substance into vein | 1,036 | $12 | $61 |
| Office visit, established patient (20-29 min) | 960 | $63 | $239 |
| Office visit, established patient (30-39 min) | 932 | $96 | $339 |
| Anti-nausea injection (ondansetron/Zofran) | 632 | $0 | $9 |
| Administration of chemotherapy into vein, 1 hour or less | 399 | $98 | $378 |
| Drug injection, under skin or into muscle | 373 | $10 | $69 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 249 | $25 | $89 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 211 | $1 | $6 |
| Injection, diphenhydramine hcl, up to 50 mg | 202 | $1 | $3 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 153 | $47 | $189 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 147 | $54 | $206 |
| Administration of chemotherapy into vein, each additional hour | 128 | $21 | $79 |
| Injection, zoledronic acid, 1 mg | 124 | $6 | $69 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 118 | $22 | $84 |
| Administration of additional new drug or substance into vein, 1 hour or less | 92 | $49 | $178 |
| New patient office visit (45-59 min) | 92 | $125 | $453 |
| Office visit, established patient (10-19 min) | 86 | $41 | $147 |
| Automated urinalysis | 50 | $2 | $8 |
| Red blood count, automated test | 46 | $4 | $10 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 45 | $15 | $56 |
| Administration of additional new drug or substance into vein using push technique | 42 | $42 | $170 |
| Drawing of blood for a medical problem | 36 | $67 | $277 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 36 | $17 | $59 |
| Injection of drug or substance into vein | 34 | $27 | $156 |
| Hospital follow-up visit, moderate complexity | 34 | $63 | $197 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 22 | $1 | $7 |
| Hospital follow-up visit, high complexity | 16 | $89 | $285 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (70%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.
Geographic Context
3.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Molthrop is a mixed practice specialist, with above-average Medicare volume (top 27% in FL), and high industry engagement (consulting-driven, top 14%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Molthrop experienced with anti-nausea injection (aprepitant)?
Does Dr. Molthrop receive payments from pharmaceutical companies?
How do Dr. Molthrop's costs compare to other medical oncologys in Winter Park?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology